Intrinsiqq
Sagimet Biosciences Inc. logo

Sagimet Biosciences Inc.

SGMT

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$569M
EPS-$1.20
P/E-7.59
P/FCF–
EV/EBITDA-5.58
FCF Yield–
Div. Yield–
Net Debt/FCF–
Sagimet Biosciences Inc. intrinsic value
52-Week Range
$4.55$11.41

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$53M

▼ -12.0% YoY

Op. Margin

–

ROIC

-26.41%

▲ +1.2pp YoY

Cash Flow & Balance Sheet

FCF

N/A

Op. Cash Flow (TTM)

-$44M

▼ -7.6% YoY

Net Debt

-$234M

Net Cash Position

Cash & Equiv.

$236M

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with SGMT

CompareIntrinsic value
ORMPOramed Pharmaceuticals Inc.
$3.57-3.25%35
DNTHDianthus Therapeutics Inc.
$84.55-0.33%10
CYCNCyclerion Therapeutics Inc.
$35.45+6.55%40
MCRBSeres Therapeutics, Inc.
$1.24-6.77%0
NWBONorthwest Biotherapeutics Inc.
$0.13-7.86%30
SCPXScorpius Holdings Inc.
$0.00+0.00%10
CPMDCannapharmaRx Inc.
$0.00+0.00%24
LPCNLipocine Inc.
$1.50+0.00%40

Held by ETFs

SGMT is in 13 US ETFs. The largest of them, with SGMT's weight in each:

Sagimet Biosciences (SGMT) in three numbers

Quality score
10/100
Best check: net debt, -$234M. Weakest: return on capital, -26.4%.
Quality
Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-7.59
Negative: a loss over the last twelve months.
Financials

Questions about Sagimet Biosciences

Is Sagimet Biosciences a high-quality business?

Sagimet Biosciences scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 2 checks computed from SEC filings. Its best check is net debt at -$234M, and its weakest is return on capital at -26.4%. The Quality tab shows every check against its target.

Does Sagimet Biosciences (SGMT) pay a dividend?

No. Sagimet Biosciences (SGMT) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 12 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in SGMT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing SGMT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.